Walmart will stop selling e-cigarettes as the number of state and federal bans increases. The move may influence other national retailers that are grappling with the complex regulations governing vaping. (CNN)

Senators are calling on the Food and Drug Administration to pull all vaping products. Four Senators sent a letter to the FDA’s acting commissioner urging him to pull all vaping pods and cartridges off the market until they can be reviewed. (CNBC

Novo Nordisk’s diabetes pill has won FDA approval. Novo sells an injectable version of this drug, semaglutide, called Ozempic. The pill, Rybelsus, is predicted to be a blockbuster. The drugmaker hopes to offer an alternative to injectable diabetes treatments. (Reuters)

President Donald Trump has signed an order to develop better flu vaccines. The executive order calls for an evaluation of vaccine manufacturing capabilities and establishes a task force to examine cost estimates. GlaxoSmithKline and Sanofi both make millions of flu vaccines in the U.S. annually. (Reuters)

Insys Therapeutics may not be able to pay its $4 billion in legal claims. The company filed for Chapter 11 bankruptcy protection in June after multiple executives were convicted of criminal racketeering charges over the marketing of its fentanyl spray. Even with Chapter 11, Insys would not be able to cover thousands of claims. (BioPharma Dive)